Latest research on MK-0518

Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. [Wikipedia]

MK-0518 indications

Furthermore, in June 2009, Isentress received an extended indication for previously untreated patients, in combination with standard treatment. [source, 2009]